Advanced search
1 file | 1.06 MB Add to list

Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro

Author
Organization
Keywords
SIPULEUCEL-T, GENERATION, LARGE NUMBERS, TLR9 AGONISTS, PROSTATE-CANCER, CANCER-IMMUNOTHERAPY, GM-CSF, MESSENGER-RNA, CYTOTOXIC T-LYMPHOCYTES, COLONY-STIMULATING FACTOR, Nanoparticle, Cancer vaccination, mRNA, Dendritic cell

Downloads

  • modelsheleen.pdf
    • peer review report
    • |
    • open access
    • |
    • PDF
    • |
    • 1.06 MB

Citation

Please use this url to cite or link to this publication:

MLA
Dewitte, Heleen et al. “Choose Your Models Wisely: How Different Murine Bone Marrow-derived Dendritic Cell Protocols Influence the Success of Nanoparticulate Vaccines in Vitro.” JOURNAL OF CONTROLLED RELEASE 195 (2014): 138–146. Print.
APA
Dewitte, H., Verbeke, R., Breckpot, K., Vandenbroucke, R., Libert, C., De Smedt, S., & Lentacker, I. (2014). Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro. JOURNAL OF CONTROLLED RELEASE, 195, 138–146.
Chicago author-date
Dewitte, Heleen, Rein Verbeke, Karine Breckpot, Roosmarijn Vandenbroucke, Claude Libert, Stefaan De Smedt, and Ine Lentacker. 2014. “Choose Your Models Wisely: How Different Murine Bone Marrow-derived Dendritic Cell Protocols Influence the Success of Nanoparticulate Vaccines in Vitro.” Journal of Controlled Release 195: 138–146.
Chicago author-date (all authors)
Dewitte, Heleen, Rein Verbeke, Karine Breckpot, Roosmarijn Vandenbroucke, Claude Libert, Stefaan De Smedt, and Ine Lentacker. 2014. “Choose Your Models Wisely: How Different Murine Bone Marrow-derived Dendritic Cell Protocols Influence the Success of Nanoparticulate Vaccines in Vitro.” Journal of Controlled Release 195: 138–146.
Vancouver
1.
Dewitte H, Verbeke R, Breckpot K, Vandenbroucke R, Libert C, De Smedt S, et al. Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro. JOURNAL OF CONTROLLED RELEASE. 2014;195:138–46.
IEEE
[1]
H. Dewitte et al., “Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro,” JOURNAL OF CONTROLLED RELEASE, vol. 195, pp. 138–146, 2014.
@article{4425954,
  author       = {Dewitte, Heleen and Verbeke, Rein and Breckpot, Karine and Vandenbroucke, Roosmarijn and Libert, Claude and De Smedt, Stefaan and Lentacker, Ine},
  issn         = {0168-3659},
  journal      = {JOURNAL OF CONTROLLED RELEASE},
  keywords     = {SIPULEUCEL-T,GENERATION,LARGE NUMBERS,TLR9 AGONISTS,PROSTATE-CANCER,CANCER-IMMUNOTHERAPY,GM-CSF,MESSENGER-RNA,CYTOTOXIC T-LYMPHOCYTES,COLONY-STIMULATING FACTOR,Nanoparticle,Cancer vaccination,mRNA,Dendritic cell},
  language     = {eng},
  pages        = {138--146},
  title        = {Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro},
  url          = {http://dx.doi.org/10.1016/j.jconrel.2014.06.024},
  volume       = {195},
  year         = {2014},
}

Altmetric
View in Altmetric
Web of Science
Times cited: